Moderna mFLUSIVA FDA Approved: First mRNA Flu Vaccine Clears U.S. Regulators for Adults 50+
FDA approves mFLUSIVA — first U.S. mRNA flu vaccine. Full approval adults 50-64; accelerated 65+. MRNA +4.3% after-hours. ACIP block limits private-insurer coverage for 50-64.
Boeing-Lockheed Rocket JV Seeks $500M as Vulcan Grounding Strains ULA Finances
ULA raises $500M via private bond after Vulcan Centaur's NSSL grounding. LMT guaranteed up to $500M; SpaceX is now the sole operational national security launch provider.
AbbVie's USD 10.9B Apogee Acquisition Funded: Bond Market Draws USD 63B Demand as Skyrizi Tops USD 5.5B
AbbVie raised USD 10B in bonds with USD 63B demand to fund its USD 10.9B Apogee Therapeutics acquisition. Skyrizi Q2 revenue hit USD 5.5B (+24%) as Humira falls 36%. FY2026 guidance raised to USD 67.6B.
CVS Health Q2 2026: $106.1B Revenue Beat, Aetna Insurance MBR Drops to 87.4% as Turnaround Accelerates
CVS Health Q2 2026 adjusted EPS $2.58 beats $1.85 estimate; Aetna MBR improves to 87.4% from 89.9%; full-year guidance raised to $7.90-$8.10.
SpaceX Targets Big Three Carriers: TMUS, T, VZ Drop 4% After-Hours as Starlink Mobile Goes Terrestrial
SpaceX's first earnings call reveals terrestrial mobile network plans. T-Mobile (TMUS), AT&T (T), Verizon (VZ) each fall 4%+ after-hours. USD 19.6B EchoStar spectrum, 2027 service launch.
Disney Q3 FY2026: Streaming Profit Doubles to USD 712M, Parks Set Record, Adjusted EPS Beats by 11%
Disney Q3 FY2026 adj. EPS USD 2.06 beat USD 1.86 estimate. Streaming OI doubled to USD 712M; domestic parks surged 27%; DIS shares rose ~3% premarket.
Uber Q2 2026 Earnings: Record $58B Bookings, But Q3 Guidance Miss Sends Stock -6%
Uber Q2 2026: gross bookings beat at USD 58B (+24%), EBITDA USD 2.82B (+33%), but Q3 guidance midpoint missed, sending shares -6%. CEO pledges USD 10B+ in robotaxi.
Eli Lilly Q2 2026 Earnings: GLP-1 Revenue Hits $14.9B, Full-Year Guidance Raised to $87 Billion
Eli Lilly Q2 2026: Revenue $22.97B (+48%), Non-GAAP EPS $8.38 beats $6.07 consensus. Mounjaro $9.9B (+91%), Zepbound $4.9B (+46%). 2026 guidance raised to $85-$87B. Retatrutide BLA Q1 2027.
Apple Seeks Injunction to Block OpenAI From Using Alleged Trade Secrets as Silicon Valley AI Talent War Turns Legal
Apple seeks a court injunction to block OpenAI from using trade secrets stolen by three ex-Apple engineers now at OpenAI. OpenAI fires back publicly.
AMD (NASDAQ: AMD) Q2 2026: Data Center Revenue Doubles to $6.7B, Powering Record $11.5B Quarter
AMD reported record Q2 2026 revenue of $11.54B (+50% YoY) as Data Center revenue doubled to $6.7B. Non-GAAP EPS beat at $1.66. Q3 guidance of ~$13B exceeds consensus despite an 8% after-hours selloff.
Electronic Arts Goes Private: $55B Saudi-Led LBO Closes Today as Q1 Bookings Disappoint
EA's USD55B Saudi PIF-led buyout closes August 4, 2026 — the largest LBO ever. Q1 net bookings miss at USD1.35B vs USD1.48B estimate; Battlefield 6 flags post-launch engagement decline.
Pfizer (PFE) Q2 2026: Non-COVID Portfolio Beats Estimates as Paxlovid Collapses 95%
Pfizer Q2 2026: adj. EPS $0.77 beat $0.68 est. (+13.2%); revenue $15.0B topped consensus. Eliquis +19%, Padcev +23%. FY2026 revenue guidance raised to $60.5–$62.5B.